Literature DB >> 26131163

Myocardial apoptosis and injury of donor hearts kept in completely beating status with normothermic blood perfusion for transplants.

Jun Kuang1, Yanpeng Sun2, Wei Wang3, Han Ke1, Hong Ye4.   

Abstract

OBJECTIVE: Normothermic blood perfusion is the developing trend of donor heart preservation. Theoretically, donor hearts preserved in a beating status may be the perfect method to reduce time-dependent ischemic injury, resuscitate marginal hearts expanding the donor pool and potentially improve the function of isolated hearts. In this study, to investigate the protective effect of normothermic blood perfusion, we maintained the donor hearts in a beating status and compared the changes of myocardial apoptosis and injury with standard hypothermic and static storage.
METHODS: Thirty rat hearts were preserved in static cold storage (Group A, n=10, stored in 4°C histidine-tryptophan-ketoglutarate solution), or in static normothermic blood perfusion (Group B, n=10, perfused with normothermic blood) or in beating status (Group C, n=10, perfused continuously with normothermic blood) for 9 hours. Myocardial injury markers including creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI), myocardial metabolic rate related indicators including Methane Dicarboxylic Aldehyde (MDA) and Adenosine Triphosphate (ATP) were investigated before and after preservation. And also TUNEL staining and mRNA and protein expression of apoptosis markers such as Bax, Bcl-2, Caspase-3 and Cleaved Caspase-3 were used to evaluated the degree of myocardial apoptosis.
RESULTS: It is found that the levels of CK-MB and cTnI in Group C were significantly lower than those of Group A and Group B (P<0.05). However, there was no significant statistical difference of ATP content among three groups. When compared with Group A and B, the quality of MDA in Group C was obviously lower. In addition, it showed that a remarkable reduction in TUNEL-positive nuclear staining in Group C but higher in other two groups. And inhibited apoptosis was also confirmed by the results of mRNA and protein expression of apoptosis markers including Bax and Bcl-2.
CONCLUSIONS: It is an effective and appropriate approach to preserve donor hearts with continuous and normothermic blood perfusion as to keep them in beating status in heart transplantation, which could reduce myocardial ischemic damage and cardiac apoptosis in long-term preservation.

Entities:  

Keywords:  Normothermic blood perfusion; apoptosis; beating status; heart transplant; myocardial injury

Year:  2015        PMID: 26131163      PMCID: PMC4483873     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Continuous perfusion of donor hearts with oxygenated blood cardioplegia improves graft function.

Authors:  Fan Zhang; Ansheng Mo; Zhaoke Wen; Yifan Zhou; Shengjing Liang; Hui Lin
Journal:  Transpl Int       Date:  2010-08-19       Impact factor: 3.782

2.  Anaesthetic considerations for noncoronary surgery on a perfused beating heart under cardiopulmonary bypass.

Authors:  Akhlesh S Tomar; Amit Banerjee; Kunal Hazari; Jeevesh Chaudhary; Sanjula Virmani; Deepak K Tempe
Journal:  Ann Card Anaesth       Date:  2002-01

3.  Crystalloid versus cold blood cardioplegia and cardiac troponin I release.

Authors:  H Pichon; S Chocron; K Alwan; G Toubin; D Kaili; P Falcoz; L Latini; F Clement; J F Viel; J P Etievent
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

4.  A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death.

Authors:  Christopher W White; Ayyaz Ali; Devin Hasanally; Bo Xiang; Yun Li; Paul Mundt; Matthew Lytwyn; Simon Colah; Julianne Klein; Amir Ravandi; Rakesh C Arora; Trevor W Lee; Larry Hryshko; Stephen Large; Ganghong Tian; Darren H Freed
Journal:  J Heart Lung Transplant       Date:  2013-07       Impact factor: 10.247

5.  N-acetylcysteine improves cardiac contractility and ameliorates myocardial injury in a rat model of lung ischemia and reperfusion injury.

Authors:  N-C Wu; T-H Chen; Y-C Yang; F-T Liao; J-C Wang; J-J Wang
Journal:  Transplant Proc       Date:  2013       Impact factor: 1.066

Review 6.  Update on heart failure, heart transplant, congenital heart disease, and clinical cardiology.

Authors:  Luis Almenar; José Luis Zunzunegui; Gonzalo Barón; José Ignacio Carrasco; Juan José Gómez-Doblas; Josep Comín; Vivencio Barrios; M Teresa Subirana; Beatriz Díaz-Molina
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2013-01-12

7.  Myocardial protection in donor heart preservation: a comparison between Bretschneider's histidine-tryptophan-ketoglutarate solution and cold blood cardioplegia.

Authors:  S-Y Sung; C-Y Lin; J-Y Song; Y-T Tsai; C-H Kao; C-Y Lee; Y-C Lin; P-S Hsu; C-S Tsai
Journal:  Transplant Proc       Date:  2014-05       Impact factor: 1.066

Review 8.  [Biomarkers of lipid peroxidation: analytical aspects].

Authors:  F Michel; D Bonnefont-Rousselot; E Mas; J Drai; P Thérond
Journal:  Ann Biol Clin (Paris)       Date:  2008 Nov-Dec       Impact factor: 0.459

9.  Normothermic ex vivo allograft blood perfusion in clinical heart transplantation.

Authors:  Michael M Koerner; Ali Ghodsizad; Uwe Schulz; Aly El Banayosy; Reiner Koerfer; Gero Tenderich
Journal:  Heart Surg Forum       Date:  2014-06       Impact factor: 0.676

10.  Improvement of functional recovery of donor heart following cold static storage with doxycycline cardioplegia.

Authors:  Evren Ozcinar; Esma N Okatan; Erkan Tuncay; Sadik Eryilmaz; Belma Turan
Journal:  Cardiovasc Toxicol       Date:  2014-03       Impact factor: 3.231

View more
  3 in total

1.  Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.

Authors:  Wei-Jin Fang; Chun-Jiang Wang; Yang He; Yu-Lu Zhou; Xiang-Dong Peng; Shi-Kun Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Eugenol protects the transplanted heart against ischemia/reperfusion injury in rats by inhibiting the inflammatory response and apoptosis.

Authors:  Wei Feng; Longyu Jin; Qianyi Xie; Lihua Huang; Zhibin Jiang; Ying Ji; Chunyun Li; Linfei Yang; Dianjun Wang
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

3.  Treatment of Donor Rat Hearts Prior to Transplantation with FLIP (FADD-Like Interleukin Beta-Converting Enzyme (FLICE)-Like Inhibitory Protein) in Cardioplegic Solution Decreased Apoptosis at Thirty Minutes Post-transplantation and Decreased Total Tyrosine Phosphorylation Levels.

Authors:  Feliu Roset; Jesus M Ureña; Tiziana Cotrufo; José Carreras; Pablo Pérez de la Ossa; Fernando Climent
Journal:  Ann Transplant       Date:  2018-02-27       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.